Compare BBCP & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBCP | SLP |
|---|---|---|
| Founded | 1983 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.0M | 293.5M |
| IPO Year | 2017 | 1996 |
| Metric | BBCP | SLP |
|---|---|---|
| Price | $6.91 | $12.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $7.50 | ★ $25.00 |
| AVG Volume (30 Days) | 83.3K | ★ 394.1K |
| Earning Date | 04-24-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.09 | 0.03 |
| Revenue | ★ $392,867,000.00 | $59,577,000.00 |
| Revenue This Year | $3.49 | $2.64 |
| Revenue Next Year | $4.54 | $6.01 |
| P/E Ratio | ★ $74.44 | $409.83 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $4.78 | $11.16 |
| 52 Week High | $7.80 | $36.43 |
| Indicator | BBCP | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 58.36 | 30.44 |
| Support Level | $6.64 | $11.16 |
| Resistance Level | $7.28 | $13.84 |
| Average True Range (ATR) | 0.27 | 0.70 |
| MACD | 0.04 | 0.14 |
| Stochastic Oscillator | 76.52 | 31.42 |
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators enables it to deliver concrete placement solutions. The company's operating segments include U.S. Concrete Pumping, U.K. Operations, and U.S. Concrete Waste Management Services, with the majority of revenue generated from the U.S. Concrete Pumping segment. Geographically, it operates in the United States and the United Kingdom, generating majority of its revenue from the United States.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.